GABRIELA DE VITA: Open Payments
NPI 1821600180 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 8 payments from 6 companies in 2025. Trend: 2023 $235 · 2024 $185 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $128 |
| Avvisto Therapeutics, LLC | 2 | $32 |
| ABBVIE INC. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Abbott Laboratories | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: Kerendia, CYCLOSET, QULIPTA, Natroba, PROCLAIM, Veozah.
Industry payments across TX — which companies pay providers there.
